Changes in Equity in Out-of-pocket Payments during the Period of Health Care Reforms: Evidence from Hungary

International Journal for Equity in Health

Wim Groot²  László Gulácsi³  Milena Pavlova¹  Petra Baji¹ 

[1] Department of Health Services Research, CAPHRI, Maastricht University Medical Center; Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands;Topinstitute Evidence-Based Education Research (TIER), Maastricht University, Maastricht, The Netherlands;Center for Public Affairs Studies Foundation, Budapest, Hungary

关键词: Hungary;    Kakwani index;    Equity;    Health care reforms;    Household expenditure;   

Others  :  828685
DOI  :  10.1186/1475-9276-11-36

 received in 2012-01-20, accepted in 2012-06-19,  发布年份 2012

【 摘 要 】

Background

At the beginning of 2007, health care reforms were implemented in Hungary in order to decrease public expenditure on health care. Reforms involved the increase of co-payments for pharmaceuticals and the introduction of co-payments for health care services.

Objective

The objective of this paper is to examine the progressivity of household expenditure on health care during the reform period, separately for expenditures on pharmaceuticals and medical devices, as well as for formal and informal patient payments for health care services.

Methods

We use data on household expenditure from the Household Budget Survey carried out by the Central Statistical Office of Hungary. We present household expenditure as a percentage of household income across different income quintiles and calculate Kakwani indexes as a measure of progressivity for a four years period (2005–2008): before, during and after the implementation of the health care reforms.

Results

We find that out-of-pocket payments on health care are highly regressive in Hungary with a Kakwani index of −0.22. In particular, households from the lowest income quintile spend an about three times larger share of their income on out-of-pocket payments (6–7 %) compared to households in the highest income quintile (2 %). Expenditures on pharmaceuticals and medical devices are the most regressive types of expenditure (Kakwani index −0.23/-0.24), and at the same time they represent a major part of the total household expenditure on health care (78–85 %). Informal payments are also regressive while expenditures on formal payments for services are the most proportional to income. We find that expenditures on formal payments became regressive after the introduction of user fees (Kakwani index −0.1). At the same time, we observe that expenditures on informal payments became less regressive during the reform period (Kakwani index increases from −0.20/-0.18 to −0.12.)

Conclusions

More attention should be paid on the protection of low-income social groups when increasing or introducing co-payments especially for pharmaceuticals but also for services. Also, it is important to eliminate the practice of informal payments in order to improve equity in health care financing.

【 授权许可】

   
2012 Baji et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 1.

【 参考文献 】

• [1]De Graeve D, Van Ourti T: The distributional impact of health financing in Europe: A review. World Economy 2003, 26(10):1459-1479.
• [2]Wagstaff A, van Doorslaer E, Calonge S, Christiansen T, Gerfin M, Gottschalk P, Janssen R, Lachaud C, Leu RE, Nolan B, et al.: Equity in the finance of health care: some international comparisons. J Health Econ 1992, 11(4):361-387.
• [3]Wagstaff A, van Doorslaer E, van der Burg H, Calonge S, Christiansen T, Citoni G, Gerdtham UG, Gerfin M, Gross L, Häkinnen U, Johnson P, John J, Klavus J, Lachaud C, Lauritsen J, Leu R, Nolan B, Perán E, Pereira J, Propper C, Puffer F, Rochaix L, Rodríguez M, Schellhorn M, Winkelhake O, et al.: Equity in the finance of health care: some further international comparisons. J Health Econ 1999, 18(3):263-290.
• [4]van Doorslaer E, Wagstaff A, van der Burg H, Christiansen T, Citoni G, Di Biase R, Gerdtham UG, Gerfin M, Gross L, Häkinnen U, John J, Johnson P, Klavus J, Lachaud C, Lauritsen J, Leu R, Nolan B, Pereira J, Propper C, Puffer F, Rochaix L, Schellhorn M, Sundberg G, Winkelhake O: The redistributive effect of health care finance in twelve OECD countries. J Health Econ 1999, 18(3):291-313.
• [5]Mastilica M, Bozikov J: Out-of-pocket payments for health care in Croatia: implications for equity. Croat Med J 1999, 40(2):152-159.
• [6]Albreht T, Klazinga N: Privatisation of health care in Slovenia in the period 1992–2008. Health Policy 2009, 90(2–3):262-269.
• [7]Gelormino E, Bambra C, Spadea T, Bellini S, Costa G: The Effects of Health Care Reforms on Health Inequalities: A Review and Analysis of the European Evidence Base. Int J Heal Serv 2011, 41(2):209-230.
• [8]Kakwani N: C: Measurement of tax progressivity: An international comparison. Econ J 1977, 87:71-80.
• [9]Kakwani N, Wagstaff A, van Doorslaer E: Socioeconomic Inequalities in Health: Measurement, Computation and Statistical Inference. J Econ 1997, 77:87-103.
• [10]Gaál P, Szigeti S, Csere M, Gaskins M, Panteli D: Hungary: Health system review. Health Syst Transit 2011, 13(5):1-266.
• [11]Boncz I, Nagy J, Sebestyen A, Korosi L: Financing of health care services in Hungary. Eur J Health Econ 2004, 5(3):252-258.
• [12]Gulácsi L, Dávid T, Dózsa C: Pricing and reimbursement of drugs and medical devices in Hungary. Eur J Health Econ 2002, 3(4):271-278.
• [13]OECD Health Data. 2011. http://www.oecd.org/document/30/0,3746,en_2649_37407_12968734_1_1_1_37407,00.html webcite Accessed 11-04-2012
• [14]Boncz I, Sebestyen A: Financial deficits in the health services of the UK and Hungary. Lancet 2006, 367(9528):2047-2048.
• [15]The Government of the Republic of Hungary: Convergence Programme of Hungary 2006–2010. Government of the Republic of Hungary, Hungary; 2006. http://pdc.ceu.hu/archive/00003232/01/Convergence_programme.pdf webcite Accessed: 20-01-2012
• [16]European Commission: Treaty of European Union.Official Journal. 191st edition. 1992. http://eur-lex.europa.eu/en/treaties/dat/11992M/htm/11992M.html webcite Accessed: 20-01-2012
• [17]Baji P, Pavlova M, Gulácsi L, Groot W: User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders. Health Policy 2011, 102(2–3):255-262.
• [18]Eligibility for Insurance Coverage. 2007.december 10 (Jogviszonyellenőrzés: mi változik 2008-tól - 2007.december 10). National Health Insurance Fund; http://www.oep.hu/portal/page?_pageid=34,35312,34_4655395,34_34207190&_dad=portal&_schema=PORTAL webcite Accessed: 20-01-2012
• [19]The Ministry of Health: The Green Book of the Hungarian Health Care. Ministry of Health, Hungary; 2006. http://www.terapia2008.hu/public/downloads/zold_konyv.pdf webcite. Accessed: 20-01-2012
• [20]Inotai A, Merész G, Kaló Z: Assessment of the pharmaceutical expenditure in Hungary. Acta Pharm Hung 2010, 80(4):162-172.
• [21]Vas G, Imhof G, Agoston I, Vas B, Betlehem J, Kresák G, Endrei D, Zemplényi A, Boncz I: The effect of reform arrangement April, 2007 on the total number of hospital beds. (A 2007. április 1-jei egészségügyi reformintézkedések hatása az összes kórházi ágyszámra). Egészségügyi Gazdasági Szemle 2009, 4:5-11.
• [22]Revenue of the National Health Insurance Funds 1993–2011: Az Egészségbiztosítási Alap bevételei 1993–2011. 2012. http://www.eski.hu/new3/adatok/adatok_tablazatok.php webcite Accessed 20-01-2012
• [23]Expenditures of the National Health Insurance Funds 1993–2011, Az Egészségbiztosítási Alap kiadásai 1993–2010. 2012. http://www.eski.hu/new3/adatok/adatok_tablazatok.php webcite Accessed 20-01-2012
• [24]Hanley GE, Morgan S, Hurley J, van Doorslaer E: Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia. Canada. Health Econ 2008, 17(12):1379-1392.
• [25]Smith S: Equity in Irish health care financing: measurement issues. Health Econ Policy Law 2010, 5(2):149-169.
• [26]Akazili J, Gyapong J, McIntyre D: Who pays for health care in Ghana? Int J Equity Health 2011., 10(26) http://www.equityhealthj.com/content/10/1/26/ webcite Accessed: 18-07-2012
• [27]O’Donnell O, van Doorslaer E, Wagstaff A, Lindelow M: Who Benefits from Health Sector Subsidies? Benefit Incidence Analysis: Chapter 14. In Analyzing Health Equity Using Household Survey Data A Guide to Techniques and Their Implementation. The World Bank, Washington; 2008:165-176.
• [28]Klavus J, Hakkinen U: Micro-level analysis of distributional changes in health care financing in Finland. J Health Serv Res Policy 1998, 3(1):23-30.
• [29]Szalay T, Pažitný P, Szalayová A, Frisová S, Morvay K, Petrovič M, van Ginneken E: Slovakia: Health system review. Health Syst Transit 2011, 13(2):1-200.
• [30]Bryndova L, Pavlokova K, Roubal T, Rokosova M, Gaskins M, Ginneken E: Czech Republic: Health System review. Health Syst Transit 2009, 11(1):1-122.
• [31]Szende Á, et al.: A magyar egészségügy finanszírozásának tehermegoszlása [The distribution of the financing burden of the Hungarian health care system]. Egészségügyi Gazdasági Szemle 2002, 40(3):23-32.
• [32]Csaba I: Zsebből fizetve – Egészségügyi magánkiadások Magyarországon [Paid out-of-pocket – private health expenditures in Hungary]. 2012. Presentation at the X. Budapest: Egészséggazdaságtani Szimpózium; 2007. http://egk.tatk.elte.hu/index.php?option=com_content&task=view&id=56&Itemid=34 webcite accessed 31 March 2012
• [33]National Audit Office: Report on the monitoring of the operation of the system of subsidies for pharmaceuticals and medical devices. (Jelentés a közgyógyellátási rendszer működésének ellenőrzéséről.). 2009. http://www.asz.hu/jelentes/0855/jelentes-a-kozgyogyellatasi-rendszer-mukodesenek-ellenorzeserol/0855j000.pdf webcite Accessed 20-01-2012
• [34]Atella V, Peracchi F, Depalo D, Rossetti C: Drug compliance, co-payment and health outcomes: evidence from a panel of Italian patients. Health Econ 2006, 15(9):875-892.
• [35]Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, Kösters JP, Vernby A: Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev 2008., 23
• [36]Consumers in Europe: Eurostat Statistical Books. Office for Official Publications of the European Communities, Luxembourg; 2009. ISSN 1831–4023, http://ec.europa.eu/consumers/strategy/consumers_europe_edition2_en.pdf webcite Accessed 20-01-2012
• [37]Szende A, Culyer AJ: The inequity of informal payments for health care: the case of Hungary. Health Policy 2006, 75(3):262-271.
• [38]Yul CP, Whynes DK, Sach TH: Equity in health care financing: The case of Malaysia. Int J Equity Health 2008, 7:15. BioMed Central Full Text
• [39]Ensor T: Informal payments for health care in transition economies. Health Policy 2004, 58(2):237-246.
• [40]Schneider P: Evidence on cost-sharing in health care: Applications to Hungary. The World Bank, Washington, DC; 2008. http://siteresources.worldbank.org/INTHSD/Resources/376278-1202320704235/SchneiderCoPaymentsHealthHungaryFeb152008.pdf webcite. Accessed 11-04-2012
• [41]Thompson R, Witter S: Informal payments in transitional economies: implications for health sector reform. Int J Health Plann Manage 2000, 15(3):169-187.
• [42]The Green Book of Hungarian Health Care [A Magyar Egészségügy Zöld Könyve]. Ministry of Health; 2006. http://www.terapia2008.hu/public/downloads/zold_konyv.pdf webcite. Accessed 11-04-2012
• [43]Boncz I, Nagy J, Kőrösi L, Kövi R, Molnár A, Kiss Z, et al.: The effect of the introduction of visit fee on the number of patient-visits to outpatient care departments in Hungary. Value Health 2008, 11(6):A368-A369.
• [44]Kőrösi L, Kövi R, Varga S, Sebestyén A, Kriszbacher I, Betlehem J, et al.: Effect of the introduction of visit fee on the number of visits to general practitioners in Hungary. Value Health 2009., 12(3)
• [45]Nagy J, Kövi R, Sebestyen A, Kiss Z, Molnár A, Kőrösi L, et al.: The effect of the introduction of hospital daily fee on the number of admissions to acute care hospital wards Hungary. Value Health 2008., 11(6)
• [46]Manning WG, Newhouse JP, Duan N, Keeler EB, Leibowitz A, Marquis MS: Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment. Am Econ Rev 1987, 77:51-277.
• [47]Newhouse JP: Free for All? Lessons from the RAND Health Insurance Experiment. Harvard University Press, Cambridge, Mass; 1993.